CILIATECH

A New Class of Implant for Surgical Glaucoma

United Kingdom · Founded 2017 · $3.9M raised

Founded
2017
Business Model
B2B
Website
cilia.tech
Total Funding
$3.9M
Last Round
$3.9M Series AApr 2023
Rounds
1

About

Ciliatech is a pioneering French biotechnology company, founded in 2017, that is developing a new class of implant to address the increasing need to treat glaucoma durably and with very minimal adverse effects. Its lead product, the Intercil Uveal Spacer, is a Cilioscleral Interpositioning Device that has been precision engineered to create a localised gap between the ciliary muscle and the sclera, working within the supraciliary space without needing to enter the eye's anterior chamber.

Summary

CILIATECH is a Biotech company based in United Kingdom, founded in 2017. It has raised $3.9M in total across 1 round, most recently a $3.9M Series A round in Apr 2023. Investors include KREAXI and BNP Paribas Développement.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AApr 2023
$3.9M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

CILIATECH on Indexed.vc
<a href="https://indexed.vc/companies/ciliatech"><img src="https://indexed.vc/api/badge/company/ciliatech" alt="CILIATECH on Indexed.vc" width="260" height="76" /></a>